BEGIN:VCALENDAR
VERSION:2.0
X-WR-CALNAME;VALUE=TEXT:Looking Forward:  The Next Generation of Biosimilars
PRODID:-//Harvard events data//EN
BEGIN:VEVENT
UID:event_985431_0
SUMMARY:Looking Forward:  The Next Generation of Biosimilars
DESCRIPTION:<p>This event is free and open to the public.  Learn more and register at:  <a data-url="http://petrieflom.law.harvard.edu/events" href="http://petrieflom.law.harvard.edu/events" target="_blank" title="http://petrieflom.law.harvard.edu/events">http://petrieflom.law.harvard.edu/events</a></p><p>Biosimilars are a type of biological product approved by FDA on the basis of being highly similar to an already approved biological reference product. This panel of experts will discuss the current state of biosimilars in the healthcare ecosystem and what comes next from a technical and legal perspective.<br><br><strong>Panelists</strong><br><em><strong>Jennifer DiGiacinto</strong></em>, RRD International<br><strong><em>Robert S. Langer</em></strong>, MIT; Consultant, Eagle Biologics<br><em><strong>Benjamin Roin</strong></em>, MIT Sloan School of Management<br>Moderator: <em><strong>Aaron S. Kesselheim</strong></em>, Brigham and Women’s Hospital/ Harvard Medical School</p>
LOCATION:Harvard Law School, Wasserstein Hall, Milstein East A (2036), Massachusetts Ave., Cambridge
STATUS:CONFIRMED
DTSTART:20170207T170000Z
DTEND:20170207T180000Z
END:VEVENT
END:VCALENDAR